Mar 28, 2023, 01:00 AM by User Not Found

Bio-IT World | Funding pipeline advancement of first-in-class extracellular protein degraders, a proteomics AI-based platform that comprehensively maps the course of a disease, a proprietary computational antibody drug discovery platform that uses machine learning to model antibody-antigen interactions, and more.

Mar 27, 2023, 17:05 PM by

Hello, Thank you for your time. I’m reaching out because I have a story perfect for your publication. The number of technicians needed in the biotechnology industry outnumbers those employed in the field. According to Executive Director of InnovATEBIO National Center for Biotechnology Education, Linnea Fletcher, "If we want to continue to produce vaccines and make other advances, we will need more technicians." On June 26th-27th, InnovATEBIO, a national biotechnology education center, will bring together biotechnology leaders in industry, government, and higher education to explore emerging technologies, build partnerships and showcase how technical education solves rising industry demands. Learn more about the summit here. As a platform dedicated to breaking news on innovative therapeutics and medical technologies, this story would definitely interest your readers. Thanks,

Mar 24, 2023, 09:11 AM by User Not Found

Bio-IT World | PacBio last week announced a new informatics method that genotypes gene paralogs and pseudogenes with high accuracy. The computational tool, named Paraphase, enables variant calling, copy number analysis and phasing by identifying the full gene sequence of each of the haplotypes for all genes and pseudogenes of the same gene family.

Mar 23, 2023, 09:41 AM by

Citeline Finalist CluePoints Show Advanced AI Capabilities RBQM leader shortlisted as a finalist for Citeline Award accolade in The Best Use of Artificial Intelligence in Clinical Trials category

Mar 23, 2023, 09:38 AM by

Mar 23, 2023, 09:37 AM by

Registry builds upon the company's robust patient-centric suite of solutions with expanded mobile capabilities and feature functionality depth

Mar 23, 2023, 09:37 AM by

Drug safety and pharmacovigilance (DSPV) teams that license access to the PubHive Navigator platform can now access the newest MedDRA version when performing signal evaluation and reporting activities.

Mar 23, 2023, 09:24 AM by

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand.

Mar 22, 2023, 09:52 AM by User Not Found

Bio-IT World | When it comes to breast cancer, the most commonly occurring estrogen receptor-positive (ER+) variety is a poor candidate for treatment with conventional immunotherapies designed to help the patient’s own immune system fight back. Unlike triple-negative breast cancer, ER+ tumors don’t have many infiltrating T cells so potentiating their function alone doesn’t make much of a difference.

Mar 22, 2023, 09:18 AM by

Former global head of new products at Sanofi Pasteur to lead Vaxess’s business and product development strategy

Mar 22, 2023, 09:18 AM by

Mar 22, 2023, 09:18 AM by

Mar 22, 2023, 09:17 AM by

Mar 22, 2023, 09:16 AM by

There are both large and small ADC molecules. A variety of biological analysis methods and platforms are needed to analyze the diversity of ADCs.

Mar 22, 2023, 09:15 AM by

92% of participants want to know about Alzheimer’s early according to new Linus Health report

Mar 22, 2023, 09:15 AM by

Driving more complete decisions for biopharmaceutical companies with modern digital pathology

Mar 21, 2023, 09:36 AM by

Flagship software platform further unifies pathology workflows and data across the R&D value chain

Mar 21, 2023, 09:36 AM by

VERICHEM LABORATORIES now offers multi-level calibration verification materials for amylase and lipase activity as part of its liquid stable, ready-to-use Enzyme ER™ Verifier Kit.

Mar 21, 2023, 09:36 AM by

Mar 21, 2023, 09:34 AM by

In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands.